Jan Weimer died on April 13, 2007 after a mostly confidential fifteen year battle with breast cancer. She left behind a legacy of creativity, devotion and selfless friendship. She mentored many women in their careers and supported many causes. As she saw her own end coming, she had a vision to help women who are suffering from cancer as she did. We had many conversations about our shared estate and vision. Jan wanted to “beat the littlef—ers” that were invading her body. She felt blessed that she could continue her career despite side effects of chemotherapy and afford a natural hair wig that kept her secret almost to the end.
Ron Levy, a major researcher in the field of cancer biology and head of Stanford Oncology, is the perfect steward for the funds raised. Stanford has committed to honor Jan’s wishes and fulfill her vision and I have committed our estate to the project.
Please join our efforts in contributing to the Jan Weimer Memorial Fund to endow a research program to suppor thte professorial chair established in her name.
Jan Weimer Faculty Chair for Breast Oncology
Allison W. Kurian, M.D., M.Sc. is an Assistant Professor of Medicine and of Health Research and Policy at Stanford University School of Medicine. She received her medical degree from Harvard Medical School, did her residency in Internal Medicine at the Massachusetts General Hospital, and completed her fellowship training in Medical Oncology along with a master’s degree in Epidemiology at Stanford University. As Associate Director of the Stanford Program for Clinical Cancer Genetics, her clinical practice centers on women at high risk for developing breast and ovarian cancer. Her research focuses on identification of women with elevated breast and ovarian cancer risk, and on development and evaluation of novel techniques for early cancer detection and risk reduction; this research is supported by grant funding from the National Institutes of Health, Susan G. Komen Breast Cancer Foundation, American Society of Clinical Oncology, California Breast Cancer Research Program, and Robert Wood Johnson Foundation.